Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk
Fleur Lien, … , Bart Staels, Philippe Lefebvre
Fleur Lien, … , Bart Staels, Philippe Lefebvre
Published February 17, 2014
Citation Information: J Clin Invest. 2014;124(3):1037-1051. https://doi.org/10.1172/JCI68815.
View: Text | PDF
Research Article Metabolism Article has an altmetric score of 10

Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk

  • Text
  • PDF
Abstract

The nuclear bile acid receptor farnesoid X receptor (FXR) is an important transcriptional regulator of bile acid, lipid, and glucose metabolism. FXR is highly expressed in the liver and intestine and controls the synthesis and enterohepatic circulation of bile acids. However, little is known about FXR-associated proteins that contribute to metabolic regulation. Here, we performed a mass spectrometry–based search for FXR-interacting proteins in human hepatoma cells and identified AMPK as a coregulator of FXR. FXR interacted with the nutrient-sensitive kinase AMPK in the cytoplasm of target cells and was phosphorylated in its hinge domain. In cultured human and murine hepatocytes and enterocytes, pharmacological activation of AMPK inhibited FXR transcriptional activity and prevented FXR coactivator recruitment to promoters of FXR-regulated genes. Furthermore, treatment with AMPK activators, including the antidiabetic biguanide metformin, inhibited FXR agonist induction of FXR target genes in mouse liver and intestine. In a mouse model of intrahepatic cholestasis, metformin treatment induced FXR phosphorylation, perturbed bile acid homeostasis, and worsened liver injury. Together, our data indicate that AMPK directly phosphorylates and regulates FXR transcriptional activity to precipitate liver injury under conditions favoring cholestasis.

Authors

Fleur Lien, Alexandre Berthier, Emmanuel Bouchaert, Céline Gheeraert, Jeremy Alexandre, Geoffrey Porez, Janne Prawitt, Hélène Dehondt, Maheul Ploton, Sophie Colin, Anthony Lucas, Alexandre Patrice, François Pattou, Hélène Diemer, Alain Van Dorsselaer, Christophe Rachez, Jelena Kamilic, Albert K. Groen, Bart Staels, Philippe Lefebvre

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2009 Total
Citations: 5 4 6 6 14 5 5 8 9 7 1 3 1 74
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (74)

Title and authors Publication Year
Circulating metabolite signatures indicate differential gut-liver crosstalk in lean and obese MASLD
Mathias Haag, Stefan Winter, Aurino M. Kemas, Julia Tevini, Alexandra Feldman, Sebastian K. Eder, Thomas Felder, Christian Datz, Bernhard Paulweber, Gerhard Liebisch, Oliver Burk, Volker Lauschke, Elmar Aigner, Matthias Schwab
JCI Insight 2025
Microbiota governs host chenodeoxycholic acid glucuronidation to ameliorate bile acid disorder induced diarrhea
Lin Z, Feng Y, Wang J, Men Z, Ma X
Microbiome 2025
Disrupting bile acid metabolism by suppressing Fxr causes hepatocellular carcinoma induced by YAP activation
Liu Y, Zhu J, Jin Y, Sun Z, Wu X, Zhou H, Yang Y
Nature Communications 2025
Gene Expression of Cyp7a1 in Liver Tissue of Type 2 Diabetic Rats Treated with Fenugreek and/or Metformin
Garg S, Kagal U
International Journal of Applied and Basic Medical Research 2025
Metformin Effects on SHIP2, AMPKs and Gut Microbiota: Recent Updates on Pharmacology.
Shivaprakash P, Beeraka NM, Madhunapantula SRV, Nikolenko VN, Basalingappa KM
Current medicinal chemistry 2025
High-throughput transcriptomics of 409 bacteria-drug pairs reveals drivers of gut microbiota perturbation.
Ricaurte D, Huang Y, Sheth RU, Gelsinger DR, Kaufman A, Wang HH
Nature Microbiology 2024
Understanding the action mechanisms of metformin in the gastrointestinal tract.
Cheng M, Ren L, Jia X, Wang J, Cong B
Frontiers in pharmacology 2024
Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets
Fleishman JS, Kumar S
Signal Transduction and Targeted Therapy 2024
Metformin: Diverse molecular mechanisms, gastrointestinal effects and overcoming intolerance in type 2 Diabetes Mellitus: A review
Mohamed S
Medicine 2024
Role of FXR in Renal Physiology and Kidney Diseases
Guo Y, Xie G, Zhang X
International journal of molecular sciences 2023
Interactions between Intestinal Homeostasis and NAD+ Biology in Regulating Incretin Production and Postprandial Glucose Metabolism
Nagahisa T, Kosugi S, Yamaguchi S
Nutrients 2023
Overexpression of NgBR inhibits high-fat diet–induced atherosclerosis in ApoE-deficiency mice
Gong K, Wang M, Wang D, Gao Y, Ma L, Yang X, Zhu X, Chen S, Zhang M, Li H, Chen Y, Hu W, Miao QR, Iwakiri Y, Liao C, Duan Y, Han J
Hepatology Communications 2023
Metformin extends the chronological lifespan of fission yeast by altering energy metabolism and stress resistance capacity.
Şeylan C, Tarhan Ç
FEMS Yeast Research 2023
Pharmacological Management of Youth with Type 2 Diabetes and Diabetic Kidney Disease: A Comprehensive Review of Current Treatments and Future Directions
Tommerdahl KL, Kula AJ, Bjornstad P
Expert Opinion on Pharmacotherapy 2023
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Cao R, Tian H, Zhang Y, Liu G, Xu H, Rao G, Tian Y, Fu X
2023
Transcriptional control of energy metabolism by nuclear receptors
C Scholtes, V Giguère
Nature Reviews Molecular Cell Biology 2022
Development of an adverse outcome pathway for intrahepatic cholestasis of pregnancy
J Waspe, A Beronius
2022
LKB1 in Intestinal Epithelial Cells Regulates Bile Acid Metabolism by Modulating FGF15/19 Production
Y Kim, S Lee, S Kim, T Kim, S Lee, J Chang, M Kweon
CMGH Cellular and Molecular Gastroenterology and Hepatology 2022
Beneficial Activities of Alisma orientale Extract in a Western Diet-Induced Murine Non-Alcoholic Steatohepatitis and Related Fibrosis Model via Regulation of the Hepatic Adiponectin and Farnesoid X Receptor Pathways
S Jeon, E Jang, G Park, Y Lee, Y Jang, K Lee, K Inn, J Lee, J Lee
Nutrients 2022
Obesity-induced miR-802 directly targets AMPK and promotes nonalcoholic steatohepatitis in mice
Sun H, Seok S, Jung H, Kemper B, Kemper JK
Molecular Metabolism 2022
Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes
Huang Y, Lou X, Jiang C, Ji X, Tao X, Sun J, Bao Z
Frontiers in Endocrinology 2022
Involvement of Autophagy in Ageing and Chronic Cholestatic Diseases
C Pinto, E Ninfole, A Benedetti, M Marzioni, L Maroni
Cells 2021
An Integrated Bile Acids Profile Determination by UHPLC-MS/MS to Identify the Effect of Bile Acids Supplement in High Plant Protein Diet on Common Carp (Cyprinus carpio)
X Wei, T Yao, FN Fall, M Xue, X Liang, J Wang, W Du, X Gu
Foods 2021
The Hormetic Effect of Metformin: “Less Is More”?
I Panfoli, A Puddu, N Bertola, S Ravera, D Maggi
International journal of molecular sciences 2021
Farnesoid X receptor via Notch1 directs asymmetric cell division of Sox9+ cells to prevent the development of liver cancer in a mouse model
M Chen, C Lu, H Lu, J Zhang, D Qin, S Liu, X Li, L Zhang
Stem Cell Research & Therapy 2021
Constitutive Androstane Receptor-Mediated Inhibition of Metformin on Phase II Metabolic Enzyme SULT2A1
X Hu, M Li, C Zhang, S Pang, T Kin
International Journal of Endocrinology 2021
Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders
MD Appelman, SW van der Veen, SW van Mil
Frontiers in Endocrinology 2021
Restoration of mRNA Expression of Solute Carrier Proteins in Liver of Diet-Induced Obese Mice by Metformin
J Le, Y Fu, Q Han, X Wei, H Ji, Y Chen, Q Wang, P Pi, J Li, X Lin, X Zhang, Y Zhang, J Ye
Frontiers in Endocrinology 2021
Resveratrol Reduces COMPopathy in Mice Through Activation of Autophagy
JT Hecht, F Coustry, AC Veerisetty, MG Hossain, KL Posey
JBMR Plus 2021
An optimized protocol with a stepwise approach to identify specific nuclear receptor ligands from cultured mammalian cells
A Berthier, B Staels, P Lefebvre
2021
Canagliflozin Facilitates Reverse Cholesterol Transport Through Activation of AMPK/ABC Transporter Pathway
Y Zhao, Y Li, Q Liu, Q Tang, Z Zhang, J Zhang, C Huang, H Huang, G Zhang, J Zhou, J Yan, Y Xia, Z Zhang, J He
Drug design, development and therapy 2021
Meta‐analysis and Consolidation of Farnesoid X Receptor Chromatin Immunoprecipitation Sequencing Data Across Different Species and Conditions
E Jungwirth, K Panzitt, HU Marschall, GG Thallinger, M Wagner
Hepatology Communications 2021
Metformin treatment for 8 days impacts multiple intestinal parameters in high-fat high-sucrose fed mice
A Bravard, C Gérard, C Defois, B Benoit, K Makki, E Meugnier, D Rainteau, J Rieusset, M Godet, H Vidal
Scientific Reports 2021
Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area
G Tulipano
International journal of molecular sciences 2021
Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
S Girisa, S Henamayee, D Parama, V Rana, U Dutta, A Kunnumakkara
2021
Metformin Preconditioning Improves Hepatobiliary Function and Reduces Injury in a Rat Model of Normothermic Machine Perfusion and Orthotopic Transplantation
AC Westerkamp, M Fujiyoshi, PJ Ottens, MW Nijsten, DJ Touw, VE de Meijer, T Lisman, HG Leuvenink, H Moshage, TA Berendsen, RJ Porte
Transplantation 2020
Metformin and cognition from the perspectives of sex, age, and disease
K Chaudhari, CD Reynolds, SH Yang
GeroScience 2020
Glibenclamide, ATP and metformin increases the expression of human bile salt export pump ABCB11
N Vats, RC Dubey, MG Sanal, P Taneja, SK Venugopal
F1000Research 2020
Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study
A Mooranian, SR Wagle, B Kovacevic, R Takechi, J Mamo, V Lam, GF Watts, M Mikov, S Golocorbin-Kon, G Stojanovic, H Al-Sallami, H Al-Salami
Scientific Reports 2020
Metformin ameliorates bile duct ligation-induced acute hepatic injury via regulation of ER stress
Lee CH, Han JH, Kim S, Lee H, Kim S, Nam DH, Cho DH, Woo CH
BMB Reports 2020
Bile acids in glucose metabolism and insulin signalling — mechanisms and research needs
TR Ahmad, RA Haeusler
Nature Reviews Endocrinology 2019
Metformin: Mechanisms in Human Obesity and Weight Loss
A Yerevanian, AA Soukas
Current Obesity Reports 2019
An attempt to reverse cardiac lipotoxicity by aerobic interval training in a high-fat diet- and streptozotocin-induced type 2 diabetes rat model
H Cai, S Chen, J Liu, Y He
Diabetology & metabolic syndrome 2019
Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
BA Blokker, M Maijo, M Echeandia, M Galduroz, AM Patterson, A Ten, M Philo, R Schungel, VG Juan, E Halilbasic, C Fuchs, GL Gall, M Milkiewicz, P Milkiewicz, JM Banales, SM Rushbrook, JM Mato, M Trauner, M Müller, ML Martínez-Chantar, M Varela-Rey, N Beraza
Hepatology 2019
Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study
RN Appleby, I Moghul, S Khan, M Yee, P Manousou, TD Neal, JR Walters, P Strnad
PloS one 2019
Bile acids in glucose metabolism in health and disease
H Shapiro, AA Kolodziejczyk, D Halstuch, E Elinav
Journal of Experimental Medicine 2018
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
L Sun, C Xie, G Wang, Y Wu, Q Wu, X Wang, J Liu, Y Deng, J Xia, B Chen, S Zhang, C Yun, G Lian, X Zhang, H Zhang, WH Bisson, J Shi, X Gao, P Ge, C Liu, KW Krausz, RG Nichols, J Cai, B Rimal, AD Patterson, X Wang, FJ Gonzalez, C Jiang
Nature Medicine 2018
Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis
S Byun, DH Kim, D Ryerson, YC Kim, H Sun, B Kong, P Yau, G Guo, HE Xu, B Kemper, JK Kemper
Nature Communications 2018
The prevalence and pregnancy outcomes of intrahepatic cholestasis of pregnancy: A retrospective clinical audit review
FW Gardiner, R McCuaig, C Arthur, T Carins, A Morton, J Laurie, T Neeman, B Lim, MJ Peek
Obstetric Medicine: The Medicine of Pregnancy 2018
β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis: Thompson et al
MD Thompson, A Moghe, P Cornuet, R Marino, J Tian, P Wang, X Ma, M Abrams, J Locker, SP Monga, K Nejak-Bowen
Hepatology 2018
Allosteric modulation of the farnesoid X receptor by a small molecule
M Gabler, J Kramer, J Schmidt, J Pollinger, J Weber, A Kaiser, F Löhr, E Proschak, M Schubert-Zsilavecz, D Merk
Scientific Reports 2018
The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects
A Mooranian, R Negrulj, R Takechi, J Mamo, H Al-Sallami, H Al-Salami
Drug Delivery and Translational Research 2018
Development and implementation of a cell-based assay to discover agonists of the nuclear receptor REV-ERBα
Y Hering, A Berthier, H Duez, P Lefebvre, B Deprez, P Gribbon, M Wolf, J Reinshagen, F Halley, J Hannemann, R Böger, B Staels, S Gul
Journal of Biological Methods 2018
Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment
Y Gu, X Wang, J Li, Y Zhang, H Zhong, R Liu, D Zhang, Q Feng, X Xie, J Hong, H Ren, W Liu, J Ma, Q Su, H Zhang, J Yang, X Wang, X Zhao, W Gu, Y Bi, Y Peng, X Xu, H Xia, F Li, X Xu, H Yang, G Xu, L Madsen, K Kristiansen, G Ning, W Wang
Nature Communications 2017
Activation of Sirt1/FXR Signaling Pathway Attenuates Triptolide-Induced Hepatotoxicity in Rats
J Yang, L Sun, L Wang, HM Hassan, X Wang, PB Hylemon, T Wang, H Zhou, L Zhang, Z Jiang
Frontiers in pharmacology 2017
AMPK improves gut epithelial differentiation and barrier function via regulating Cdx2 expression
X Sun, Q Yang, CJ Rogers, M Du, MJ Zhu
Cell Death and Differentiation 2017
Towards natural mimetics of metformin and rapamycin
A Aliper, L Jellen, F Cortese, A Artemov, D Karpinsky-Semper, A Moskalev, AG Swick, A Zhavoronkov
Aging 2017
Alteration of FXR phosphorylation and sumoylation in liver in the development of adult catch-up growth
X Hu, Q Zhang, J Zheng, W Kong, HH Zhang, TS Zeng, JY Zhang, J Min, C Wu, LL Chen
Experimental biology and medicine (Maywood, N.J.) 2017
Retinoid X Receptors Intersect the Molecular Clockwork in the Regulation of Liver Metabolism
SD Cosmo, G Mazzoccoli
Frontiers in Endocrinology 2017
In vivo therapeutic effect of combination treatment with metformin and Scutellaria baicalensis on maintaining bile acid homeostasis
K Han, S Bose, JH Wang, S Lim, YW Chin, YM Kim, H Choi, H Kim, W Huang
PloS one 2017
Metformin: a review of its potential indications
YW Wang, SJ He, X Feng, J Cheng, YT Luo, L Tian, Q Huang
Drug design, development and therapy 2017
The logic of transcriptional regulator recruitment architecture at cis -regulatory modules controlling liver functions
J Dubois-Chevalier, V Dubois, H Dehondt, P Mazrooei, C Mazuy, AA Sérandour, C Gheeraert, P Guillaume, E Baugé, B Derudas, N Hennuyer, R Paumelle, G Marot, JS Carroll, M Lupien, B Staels, P Lefebvre, J Eeckhoute
Genome research 2017
Nuclear receptors and AMPK: can exercise mimetics cure diabetes?
CE Wall, RT Yu, AR Atkins, M Downes, RM Evans
Journal of Molecular Endocrinology 2016
Altered Microbiota Contributes to Reduced Diet-Induced Obesity upon Cold Exposure
M Ziętak, P Kovatcheva-Datchary, LH Markiewicz, M Ståhlman, LP Kozak, F Bäckhed
Cell Metabolism 2016
Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats
X Li, R Liu, L Luo, L Yu, X Chen, L Sun, T Wang, PB Hylemon, H Zhou, Z Jiang, L Zhang
Archives of Toxicology 2016
Metformin as a Tool to Target Aging
N Barzilai, JP Crandall, SB Kritchevsky, MA Espeland
Cell Metabolism 2016
Metformin and the gastrointestinal tract
LJ McCreight, CJ Bailey, ER Pearson
Diabetologia 2016
Differential modulation of FXR activity by chlorophacinone and ivermectin analogs
CW Hsu, JH Hsieh, R Huang, D Pijnenburg, T Khuc, J Hamm, J Zhao, C Lynch, R Beuningen, X Chang, R Houtman, M Xia
Toxicology and Applied Pharmacology 2016
Post-translational modifications of lipid-activated nuclear receptors: Focus on metabolism
NB Salles, MC Gage, I Pineda-Torra
Endocrinology 2016
Structural Basis for Small Molecule NDB ( N -Benzyl- N -(3-( tert -butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) Benzamide) as a Selective Antagonist of Farnesoid X Receptor α (FXRα) in Stabilizing the Homodimerization of the Receptor
X Xu, X Xu, P Liu, Z Zhu, J Chen, H Fu, L Chen, L Hu, X Shen
The Journal of biological chemistry 2015
Nuclear bile acid signaling through the farnesoid X receptor
C Mazuy, A Helleboid, B Staels, P Lefebvre
Cellular and Molecular Life Sciences 2014
Bridging cell surface receptor with nuclear receptors in control of bile acid homeostasis
S Li, A Ni, G Feng
Acta Pharmacologica Sinica 2014
Bile acids are nutrient signaling hormones
H Zhou, PB Hylemon
Steroids 2014
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
149 readers on Mendeley
See more details